Adgero Biopharmaceuticals Holdings adgerobiopharm.com


Public list: Pharma Startups (4733) Cancer Therapeutics (1136)

Adgero Biopharmaceuticals Holdings is a privately-held biopharmaceutical company focused on building a robust pipeline by advancing its proprietary late stage photodynamic therapy (PDT) product with broad utility for the treatment of serious oncology indications. PDT is a treatment that uses light-sensitive compounds, or photosensitizers, that, when exposed to specific wavelengths of light, act as a catalyst to produce a form of oxygen that induces local tumor cell death.

Adgero Biopharmaceuticals Holdings is a privately-held biopharmaceutical company focused on building a robust pipeline by advancing its proprietary late stage photodynamic therapy (PDT) product with broad utility for the treatment of serious oncology...Show all

Company (Alive / Active)

Phone: 609-917-9796

Fax:

4365 US 1 South
Ste 211
Princeton, 08540
New Jersey, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Adgero Biopharmaceuticals Holdings $5.5M Feb 22, 2017

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Adgero Biopharmaceuticals Holdings Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 2 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)